We are live on ! Find out more
ONC

BeOne Medicines Ltd

253 hedge funds and large institutions have $20.4B invested in BeOne Medicines Ltd in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 79 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 79

7% more capital invested

Capital invested by funds: $19.1B → $20.4B (+$1.32B)

0.01% more ownership

Funds ownership: 4.65%4.67% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

5% less funds holding

Funds holding: 266253 (-13)

24% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 37

32% less call options, than puts

Call options by funds: $31.3M | Put options by funds: $46M

Holders
253
Holders Change
-13
Holders Change %
-4.89%
% of All Funds
4.43%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.19%
New
28
Increased
97
Reduced
79
Closed
37
Calls
$31.3M
Puts
$46M
Net Calls
-$14.7M
Net Calls Change
-$13.4M
Name Holding Trade Value Shares
Change
Change in
Stake
EOJOAM
101
E. Ohman J:or Asset Management
Sweden
$3.27M
PA
102
Profund Advisors
Maryland
$3.18M +$13.4K +41 +0.5%
AIMCA
103
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.05M
Manulife (Manufacturers Life Insurance)
104
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.01M +$262K +800 +11%
Caisse de Depot et Placement du Quebec (CDPQ)
105
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$2.9M +$229K +700 +10%
Allianz Asset Management
106
Allianz Asset Management
Germany
$2.84M -$1.88M -5,738 -42%
E
107
Ergoteles
New York
$2.77M +$1.37M +4,199 +122%
Russell Investments Group
108
Russell Investments Group
United Kingdom
$2.66M +$1.51M +4,622 +170%
GC
109
Guggenheim Capital
Illinois
$2.64M -$434K -1,327 -15%
MME
110
Meag Munich Ergo
Germany
$2.61M
PL
111
Parkwood LLC
Ohio
$2.56M +$489K +1,495 +27%
TAMH
112
Taikang Asset Management (HK)
Hong Kong
$2.54M
VIA
113
Vident Investment Advisory
Georgia
$2.32M +$101K +310 +5%
Qube Research & Technologies (QRT)
114
Qube Research & Technologies (QRT)
United Kingdom
$2.31M -$3.48M -10,656 -63%
GIBU
115
Gulf International Bank (UK)
United Kingdom
$2.18M
SAM
116
Sectoral Asset Management
Quebec, Canada
$2.18M
SEI Investments
117
SEI Investments
Pennsylvania
$2.18M -$145K -445 -7%
State of Wisconsin Investment Board
118
State of Wisconsin Investment Board
Wisconsin
$2.17M
Vontobel Holding
119
Vontobel Holding
Switzerland
$2.17M +$623K +1,905 +47%
Nomura Holdings
120
Nomura Holdings
Japan
$2.1M
SFI
121
Susquehanna Fundamental Investments
Pennsylvania
$2.06M +$1.85M +5,670 New
Swedbank
122
Swedbank
Sweden
$1.96M
KBC Group
123
KBC Group
Belgium
$1.94M -$1.76M -5,373 -50%
PAM
124
Panagora Asset Management
Massachusetts
$1.82M +$22.2K +68 +1%
Flossbach Von Storch
125
Flossbach Von Storch
Germany
$1.81M +$1.63M +5,000 New

ONC Hedge Fund Activity: Q3 2021 in Review

253 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2021, worth a combined $20.4B — up 6.9% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of ONC and 28 opened new positions — a net loss of 9 holders — while 79 trimmed existing stakes and 97 added.

The largest buyer was Invesco, adding an estimated $190M. The largest seller was Fidelity Investments, cutting an estimated $156M.

  • 253 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2021, down from 266 in Q2 2021.
  • Funds reported $20.4B of BeOne Medicines Ltd stock for Q3 2021, up 6.9% quarter-over-quarter.
  • 28 funds opened new BeOne Medicines Ltd positions in Q3 2021 and 37 closed out, a net change of -9 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2021 was Invesco, an estimated $190M added.
  • The largest BeOne Medicines Ltd seller in Q3 2021 was Fidelity Investments, an estimated $156M sold.

Based on aggregated 13F filings for Q3 2021.